Literature DB >> 11053192

Seeing what you want to see in randomised controlled trials. Authors' choice of study was ill informed.

R Holman.   

Abstract

Mesh：

Year:  2000        PMID： 11053192      PMCID： PMC1118858          DOI： 10.1136/bmj.321.7268.1078

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study.

Authors:  J McCormack; T Greenhalgh
Journal:  BMJ       Date:  2000-06-24

2.  How do two meta-analyses of similar data reach opposite conclusions?

Authors:  M Lindbaek; P Hjortdahl
Journal:  BMJ       Date:  1999-03-27

3.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

4.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.

Authors:  A I Adler; I M Stratton; H A Neil; J S Yudkin; D R Matthews; C A Cull; A D Wright; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

5.  Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults.

Authors:  T Fahey; N Stocks; T Thomas
Journal:  BMJ       Date:  1998-03-21

6.  The rhetoric of research.

Authors:  R Horton
Journal:  BMJ       Date:  1995-04-15

7.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321
  8 in total
  1 in total

1.  Patients' and healthcare professionals' perspectives on the idiopathic pulmonary fibrosis care journey: a qualitative study.

Authors:  Anouk Delameillieure; Fabienne Dobbels; Sarah Vandekerkhof; Wim A Wuyts
Journal:  BMC Pulm Med       Date:  2021-03-18       Impact factor: 3.317
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.